Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infection.
about
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan.Hepatitis C virus resistance to the new direct-acting antivirals.Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment.Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use.Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV.Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study.Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy.Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy.Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment.The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir.Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis.5' UTR and NS5B-based genotyping of hepatitis C virus in patients from Damietta governorate, EgyptNatural polymorphisms in the resistance associated sites of HCV-G1 NS5B domain and correlation with geographic origin of HCV isolates
P2860
Q38755098-5F12AD41-076E-4DC3-981D-85057DA93123Q38887954-781181B7-5C89-4AF4-BB78-1FE9D65D5D0AQ39092977-62C65981-E334-4561-A548-AAF5C673564BQ39301797-7ED0E632-6EAB-491C-BBF2-C32EB7C29103Q39307349-F44AD554-2529-4048-BFCF-C519A988544EQ40116908-305371C2-B8C8-484E-8D09-CC2A4B10D7E2Q40278965-374C40DC-3612-41C7-9CEA-0E5FCC834AC0Q40286520-53F039BA-1690-47DE-B84A-2C144BDD0AD9Q40413390-FE6A5009-50C5-4B1F-A025-88E527F3ED6BQ55212538-9D8950A6-946D-4D63-97D7-08FBDE5D3AC4Q55303958-1CABC51C-2B1D-4923-BE1E-0AC916FD435DQ56955337-13F54808-90C9-49A0-811D-D9FA70EB5C9DQ58725182-B7257CF3-CC80-4BB4-9CED-EFE5905F8481
P2860
Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infection.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Prevalence and characteristics ...... C virus genotype 1b infection.
@en
type
label
Prevalence and characteristics ...... C virus genotype 1b infection.
@en
prefLabel
Prevalence and characteristics ...... C virus genotype 1b infection.
@en
P2093
P2860
P356
P1433
P1476
Prevalence and characteristics ...... C virus genotype 1b infection
@en
P2093
Atsushi Nagasaka
Fumiyuki Sato
Hideaki Kikuchi
Katsumi Terashita
Kazushi Yamasaki
Ken Furuya
Kenichi Kumagai
Kenichi Morikawa
P2860
P304
P356
10.1111/HEPR.12685
P577
2016-04-08T00:00:00Z